Pulse Biosciences (PLSE) Share-based Compensation (2020 - 2025)
Historic Share-based Compensation for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $5.6 million.
- Pulse Biosciences' Share-based Compensation rose 8836.35% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year increase of 12965.37%. This contributed to the annual value of $13.6 million for FY2024, which is 8919.37% up from last year.
- According to the latest figures from Q3 2025, Pulse Biosciences' Share-based Compensation is $5.6 million, which was up 8836.35% from $5.2 million recorded in Q2 2025.
- Pulse Biosciences' 5-year Share-based Compensation high stood at $7.0 million for Q1 2021, and its period low was $723000.0 during Q3 2022.
- For the 5-year period, Pulse Biosciences' Share-based Compensation averaged around $3.0 million, with its median value being $2.1 million (2024).
- As far as peak fluctuations go, Pulse Biosciences' Share-based Compensation plummeted by 7928.55% in 2022, and later surged by 34705.88% in 2023.
- Over the past 5 years, Pulse Biosciences' Share-based Compensation (Quarter) stood at $3.6 million in 2021, then crashed by 79.29% to $748000.0 in 2022, then skyrocketed by 347.06% to $3.3 million in 2023, then surged by 103.14% to $6.8 million in 2024, then decreased by 17.31% to $5.6 million in 2025.
- Its Share-based Compensation was $5.6 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.7 million in Q1 2025.